Our Human Products
Antibacterial Antifungal |
||||
| S.N. | Product Name | Label claim | Pack Size | Action & Use |
| ANTIBACTERIAL ANTIFUNGAL, ANTISCABIES EXTERNAL LIQUIDS | ||||
| 1 | Formulation 1 | Contains | 100 ml | Anteseptic Liquid |
| Chlorhexidine Gluconate IP 0.3% v/v | 500 ml | |||
| Cetrimide IP 0.06% w/v | 1000 ml | |||
| Colour Tatrazine & Sunset Yellow FCF | 5 Ltr | |||
| 2 | Formulation 2 | Contains | 5000 ml | Anteseptic Liquid |
| Chlorhexidine Gluconate BP 20% v/v | ||||
| Solution Eq. To chlorhexidine Gluconate | ||||
| IP 4 % w/v | ||||
| Colour: Carmoisine | ||||
| 3 | Formulation 3 | Each 100ml Contains: | 500ml | Anteseptic Liquid |
| Chlorhexidine Gluconate 0.3g | ||||
| Cetrimide 3.0g | ||||
| n-Propyl Alcohol (as preservative) 2.84% m/v | ||||
| 4 | Formulation 4 | 2-Propanol 70% v/v BP | 100ml | |
| 5 | Formulation 5 | Contains | 500 ml | Anteseptic Liquid |
| Chlorhexidine Gluconate BP 5 % | ||||
| Solution ( Dilute ) | ||||
| 6 | Formulation 6 | Contains | 100 ml | Anteseptic Liquid |
| Chloroxylenol BP 3% w/v | ||||
| Terpineol BP 2% w/v | ||||
| Soap/Detergent base | ||||
| 7 | Formulation 7 | Contains | 100 ml | Antiseptic |
| Chloroxylenol BP 3% w/v | Germicidal | |||
| Chlorhexidine Gluconate BP 0.3% v/v | (Topical Skin | |||
| strong Cetrimides solution Eq.to | infection,irrigation | |||
| Cetrimide 0.4 % w/v | of wounds surgical | |||
| infection & also | ||||
| disinfectant ) | ||||
| 8 | Formulation 8 | Each gm Contains | 500 gm | Antiseptic |
| Dicloroxylenol IP 1% w/w | ||||
| Terpineol BP 1% w/w | ||||
| Phenol IP 0.25 % | ||||
| In Lubricant base | ||||
| 9 | Formulation 9 | Contains | 25 gm | Antiseptic |
| Chloroxylenol USP 0.6% w/v | (used for topicaol | |||
| Chlorhexidine Gluconate | antiseptic on minor | |||
| solution BP 0.3% w/w | burns,wounds skin | |||
| cream base | infections,surgical | |||
| infection) | ||||
| 10 | Formulation 10 | Contains | 25 gm | Antibacterial |
| Cetrimide BP 0.5 % w/w | ||||
| Chlorhexidine Gluconate | ||||
| solution BP 0.1% w/w | ||||
| ( Eq. To Chlorhexidine Gluconate) | ||||
| Water miscible cream base Q.S. | ||||
| 11 | Formulation 11 | Chloroxylenol IP 3% | 100ml | Antiseptic |
| Chlorhexidine Gluconate Solution IP 0.3% | 500ml | (used for topicaol | ||
| Strong Cetrimide Solution equivalent to | 1ltr | antiseptic on minor | ||
| Cetrimide IP 0.4% w/v | burns,wounds skin | |||
| infections,surgical | ||||
| infection) | ||||
| 12 | Formulation 12 | Chlorooxylenol IP 0.6% w/w | 25gm | Antiseptic Cream |
| Chlorhexidine Gluconate Solution IP 0.3% w/w | ||||
| Cream base Q.s | ||||
| 13 | Formulation 13 | Composition : | 25gm | Antiseptic Cream |
| Chlorhexidine Gluconate Solution BP | ||||
| Equivalent to Chlorhexidine Gluconate 1% w/w | ||||
| 14 | Formulation 14 | Contains | 100 ml | Antimicrobial |
| Povidone – Iodine IP 5% w/v | 500 ml | Antibacterial | ||
| (Available Iodine 0.5% w/v) | ||||
| Povidone Iodine USP 7.5% w/v | 500ml | Antimicrobial | ||
| Antibacterial | ||||
| 15 | Formulation 15 | Contains | 30 ml | Antimicrobial |
| Povidone –Iodine IP 5% w/v | 100ml | Antibacterial | ||
| ( Available Iodine 0.5% w/v ) | ||||
| Metronidazole IP 1% w/v | ||||
| Purified Water IP | ||||
| 16 | Formulation 16 | Povidone-Iodine USP 10.0% w/v | 100ml | |
| 17 | Formulation 17 | Each gm Contains | 4 gm | Antimicrobial |
| Povidone Iodine IP 5% w/w | 15 gm | Antibacterial | ||
| (Available Iodine 0.5% w/w ) | ||||
| Metronidazole IP 1% w/w | ||||
| Water Soluble Ointment base q.s. | ||||
| 18 | Formulation 18 | Contains | 2 Ltr | Antiscabies |
| Gamabenzene Hexachloride IP 1% w/v | Scabicide/ | |||
| Cetrimide IP 0.1% w/v | Pediculocide | |||
| Benzocaine IP 06% w/v | (Scabies, | |||
| Pediculosis) | ||||
| 19 | Formulation 19 | Salicylic Acid BP 10% w/v | 100ml | Keratolytic, anti-dandruff |
| Potassium Iodide BP 1.25% w/v | sporotrichosis | |||
| Iodine BP 1.25% w/v | ||||
| 20 | Formulation 20 | Composition: | 50gm | |
| Gamabenzene Hexachloride BP 1% w/v | 2 Ltr | Antiscabies | ||
| Scabicide/ | ||||
| Gamma Benzene Hexachloride BP 1% w/w | Pediculocide | |||
| (Scabies, | ||||
| Pediculosis) | ||||
| 21 | Formulation 21 | Contains | 100 ml | Acaricide |
| Benzyl Benzoate BP 25 % w/v | 500 ml | (Scabies, | ||
| Emulsifying wax 2% | 1000 ml | Pediculosis) | ||
| 22 | Formulation 22 | Benzyl Benzoate BP 25% w/v | 100 ml | Acaricide |
| 500 ml | (Scabies, | |||
| 1000 ml | Pediculosis) | |||
| 23 | Formulation 23 | Composition: | 50 gm | Antiscabies |
| Gama Benzene Hexachloride BP 1 w/v | ||||
| 24 | Formulation 24 | Each gm contain | 20 gm | Antifungal |
| Ketoconazole USP 2% w/w | ||||
| cream base Q.S. | ||||
| 25 | Formulation 25 | Each gm Contains: | 20 gm | Antifungal |
| Ketoconazole BP 20mg | ||||
| Excipients q.s. | ||||
| 26 | Formulation 26 | Ketoconazole BP 2% w/v | 75ml | Antifungal |
| 27 | Formulation 27 | Composition: | 100ml | Antifungal, anti dandruff |
| Ketoconazole BP 2% w/v | ||||
| Zinc Pyrithione (ZPTO) 1% w/v | ||||
| Base q.s | ||||
| 28 | Formulation 28 | Each ml contain | 100 ml | Antifungal |
| Ketoconazole USP 2% w/w | ||||
| 29 | Formulation 29 | Each ml Contains: | 100 ml | Antifungal |
| Ketoconazole BP 10mg | ||||
| Excipients q.s. | ||||
| 30 | Formulation 30 | Each ml Contains: | 100 ml | Antifungal |
| Ketoconazole BP 20mg | ||||
| Excipiens q.s. | ||||
| 31 | Formulation 31 | Salicylic Acid IP 2% w/v | Antifungal | |
| Zinc Pyrithione 1% w/v | ||||
| Colour: Ponceaur 4R | ||||
| 32 | Formulation 32 | Salicylic Acid IP 6% w/v | Antifungal | |
| Colour: Sunset Yellow FCF | ||||
| 33 | Formulation 33 | Salicylic Acid IP 2% w/v | Antifungal | |
| Colour Brilliant Blue FCF | ||||
| 34 | Formulation 34 | Each gm Contains | 20 gm | Antifungal |
| Nystatin USP 100000 IU | ||||
| Ointment Base Q.S. | ||||
| 35 | Formulation 35 | Each 4gms contains | 25gm | Antifungal |
| Nystatin USP 100000IU | ||||
| 36 | Formulation 36 | Contains | 5 gm | Antifungal |
| Clotrimazole IP 1% w/w | 10 gm | Antibacterial | ||
| Beclomethasone Dipropinate IP 0.025 w/w | ||||
| Gentamicin Sulphate IP | ||||
| e. q. to Gentamicin base | ||||
| ( 1000 u / mg) 0.1% w/w | ||||
| Cream Base q.s | ||||
| 37 | Formulation 37 | Composition: | 30 gm | Antifungal |
| Clotrimazole IP 1% w/w | 5 gm | Antibacterial | ||
| Neomycin Sulphate IP | ||||
| e.q. to Neomycin 0.5% w / w | ||||
| Beclomethasone Dipropinate IP 0.025 w/w | ||||
| Cream Base Q.S. | ||||
| Preservative | ||||
| Sodium Methyl Paraben IP 0.25% w/w | ||||
| Propyl Paraben IP 0.025% w/w | ||||
| 38 | Formulation 38 | Each gm contains | 15 gm | Topical |
| Betamethasone Dipropinate USP 0.643 mg | 30gm | Antifungal | ||
| Gentamycin Solphate | Antibacterial | |||
| Gentamycin base 1mg | (Fungal &bacterial | |||
| Tolnaftate USP 10mg | skin infection) | |||
| Iodochlorohydroxy quinoline 10mg | ||||
| Chlorocrosol B 1mg | ||||
| cream base | ||||
| 39 | Formulation 39 | Clotrimazole USP 1% w/w | 15gm | Topical |
| Betamethasone Dipropionate USP | Antifungal | |||
| Eqvt. To Betamethasone 0.05% w/w | Antibacterial | |||
| Neomycin Sulphate USP | (Fungal &bacterial | |||
| eq. to Neomycin 0.35% w/w | skin infection) | |||
| Chlorocresol USP (as preservative) 0.1% w/w | ||||
| Cream Base q.s | ||||
| 40 | Formulation 40 | Beclomethasan Dipropionate USP 0.025% w/w | ||
| Clotrimazole IP 1% w/w | ||||
| Neomycin Sulphate IP | ||||
| Equivalent to Neomycin base 0.50% w/w | ||||
| Preservative | ||||
| Chlorocresol IP 0.10% w/w | ||||
| In a cream base | ||||
| 41 | Formulation 41 | Clotrimazole BP 1% w/w | 10gm | Topical |
| Beclomethasone Dipropionate BP 0.025% w/w | Antifungal | |||
| Preservative: | Antibacterial | |||
| Chlorocresol IP 0.1% w/w | (Fungal &bacterial | |||
| Bronopol BP 0.02% w/w | skin infection) | |||
| In Cream base | ||||
| 42 | Formulation 42 | Betamethasone Dipropionate BP | 20 gm | Anti-inflammatory |
| Eq. to Betamethasone BP 0.05% w/w | corticosteroid | |||
| Salicylic Acid BP 3.00 w/w | ||||
| Urea BP 10.0% w/w | ||||
| Lactic Acid BP 3.00% w/w | ||||
| Sodium Lactate | ||||
| eq.Lactic Acid BP 2.00% w/w | ||||
| 43 | Formulation 43 | Contains | 30 gm | Corticosteroid |
| Beclomethasone | 50 gm | (Steroid responsive | ||
| Dipropionate BP 0.025 % w/w | dermatoses such | |||
| as allergic or contact | ||||
| dermatitis,psoriasis | ||||
| seborrhoeic | ||||
| Dermatitis procreates | ||||
| 44 | Formulation 44 | Each gm Contains | 30 gm | Corticosteroid |
| Betamethasone | 15 gm | (Steroid responsive | ||
| Dipropionate USP 0.05 % w/w | dermatoses such | |||
| Eq, to Betamethasone | as allergic or contact | |||
| dermatitis,psoriasis | ||||
| seborrhoeic | ||||
| Dermatitis procreates | ||||
| 45 | Formulation 45 | Betamethasone Sodium Phosphate USP | 25gm | Corticosteroid |
| Eqvt. To Betamethasone 0.1% w/w | ||||
| Sterilized Paraffin base q.s | ||||
| 46 | Formulation 46 | Each gm Contains | 15 gm | Corticosteroid |
| Clobetasol Propionate USP 0.05 % w/w | 50 gm | (Steroid responsive | ||
| dermatoses such | ||||
| as allergic or contact | ||||
| dermatitis,psoriasis | ||||
| seborrhoeic | ||||
| Dermatitis procreates | ||||
| 47 | Formulation 47 | Clobetasol Propionate BP 0.05% w/w | 25gm | |
| Ointment base | ||||
| 48 | Formulation 48 | Betamethasone Valerate BP | 15gm | Corticosteroid |
| Equivalent to Betamethasone 0.1% w/w | ||||
| Chlorocresol BP (As preservative) 0.1% w/w | ||||
| Ointment base q.s | ||||
| 49 | Formulation 49 | Betamethasone Valerate BP | ||
| eq. to Betamethasone 0.1% w/v | ||||
| 50 | Formulation 50 | Composition: | 20 gm | Antifungal |
| Clotrimazole BP 1 w/w | Antibacterial | |||
| 51 | Formulation 51 | Clotrimazole USP 1.0% w/w | 50gm | |
| Cream base Q.S. | ||||
| 52 | Formulation 52 | Each gm Contains: | 30gm | Candidal & trichomonal |
| Clotrimazole USP 2% w/w | Vaginitis | |||
| 53 | Formulation 53 | Each gm Contains | 20 gm | Antifungal |
| Tolnaftate USP 1 % w/w | Antibacterial | |||
| 54 | Formulation 54 | Each ml contains: | 10ml | Antifungal |
| Tolnaftate USP …. 1%w/w | Antibacterial | |||
| 55 | Formulation 55 | Contains | 30 gm | Local anesthetic |
| Lignocaine Hydrochloride IP 2.0 % w/w | ||||
| Methylparaben IP 0.10% w/v | ||||
| ( as preservative ) | ||||
| Propyl paraben IP 0.05% w/v | ||||
| ( as preservative ) | ||||
| In water miscible base | ||||
| 56 | Formulation 56 | Composition | 30gm | Local anesthetic |
| Lignocaine Hydrochloride IP equt to | ||||
| Anhydrous Lignocaine | ||||
| Hydrochloride 2.000%w/v | ||||
| Methylparaben IP (As preservative) | ||||
| 0.061% w/v | ||||
| Propylparaben IP (As preservative) | ||||
| 0.027% w/v | ||||
| Water –soluble gel base in | ||||
| Purified water IP ……..q.s | ||||
| 57 | Formulation 57 | Each ml Contains | 10 ml | Local anesthetic |
| Lidocaine Hydrochloride I.P. 42.66 mg | ||||
| Methyl Paraben IP 0.1% w/v. | ||||
| Propyl Paraben IP 0.05% w/v. | ||||
| (An Preservative) | ||||
| 58 | Formulation 58 | Lidocaine Hydrochloride BP 2%w/v | 30gm | Local anesthetic |
| (Anhydrous) | ||||
| Methyl Paraben USP 0.10%w/v | ||||
| (As Preservative) | ||||
| Propyl Paraben USP 0.05%w/v | ||||
| (As Preservative) | ||||
| In water Miscible Base q.s. | ||||
| 59 | Formulation 59 | Lidocaine USP 2.5% w/w | 30gm | Local anesthetic |
| Ointment base q.s | ||||
| 60 | Formulation 60 | Lidocaine USP 5% w/w | 30gm | Local anesthetic |
| Ointment base q.s | ||||